全文获取类型
收费全文 | 1852篇 |
免费 | 225篇 |
国内免费 | 63篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 63篇 |
妇产科学 | 6篇 |
基础医学 | 225篇 |
口腔科学 | 55篇 |
临床医学 | 238篇 |
内科学 | 431篇 |
皮肤病学 | 34篇 |
神经病学 | 93篇 |
特种医学 | 280篇 |
外科学 | 117篇 |
综合类 | 67篇 |
预防医学 | 133篇 |
眼科学 | 13篇 |
药学 | 203篇 |
肿瘤学 | 175篇 |
出版年
2021年 | 26篇 |
2020年 | 11篇 |
2019年 | 19篇 |
2018年 | 22篇 |
2017年 | 19篇 |
2016年 | 28篇 |
2015年 | 29篇 |
2014年 | 38篇 |
2013年 | 66篇 |
2012年 | 59篇 |
2011年 | 60篇 |
2010年 | 52篇 |
2009年 | 57篇 |
2008年 | 38篇 |
2007年 | 87篇 |
2006年 | 57篇 |
2005年 | 73篇 |
2004年 | 48篇 |
2003年 | 50篇 |
2002年 | 59篇 |
2001年 | 61篇 |
2000年 | 54篇 |
1999年 | 56篇 |
1998年 | 63篇 |
1997年 | 75篇 |
1996年 | 65篇 |
1995年 | 75篇 |
1994年 | 39篇 |
1993年 | 51篇 |
1992年 | 39篇 |
1991年 | 42篇 |
1990年 | 44篇 |
1989年 | 72篇 |
1988年 | 58篇 |
1987年 | 48篇 |
1986年 | 38篇 |
1985年 | 37篇 |
1984年 | 24篇 |
1983年 | 23篇 |
1982年 | 28篇 |
1981年 | 23篇 |
1980年 | 27篇 |
1979年 | 20篇 |
1978年 | 19篇 |
1977年 | 19篇 |
1976年 | 17篇 |
1975年 | 20篇 |
1974年 | 11篇 |
1973年 | 9篇 |
1971年 | 8篇 |
排序方式: 共有2140条查询结果,搜索用时 31 毫秒
1.
Sebastian Bonner Thomas Matte Mitchell Rubin Joanne K Fagan Jennifer Ahern David Evans 《The Journal of asthma》2006,43(1):31-35
Although studies have documented underuse of controller medications and overuse of short-acting inhaled ss(2)-agonist among children with persistent asthma in disadvantaged communities, the persistence of oral ss(2)-agonist use in pediatric practice has not been studied since inhaled short-acting ss(2)-agonists became widespread. We describe medications used to treat asthma among children 3 to 5 years of age at 10 Head Start and other subsidized preschool centers in East and Central Harlem, New York City. We interviewed 149 parents/guardians of children who were identified as having probable asthma based on physician's diagnosis, persistent symptoms, hospitalization, and medication use. We classified 86 of the 149 children (58%) as having current persistent asthma. Only 15 of them (17%) were reported to have used controller medications at least 5 days/week in the last 4 weeks-only 2 of whom used inhaled corticosteroids. By contrast, 53 children (62%) used oral ss(2)-agonist in the last 4 weeks, often (72%) in conjunction with nebulized or inhaled short-acting ss(2)-agonist. Use of oral ss(2)-agonist was associated with more severe symptoms. This study documents the continued widespread use of oral ss(2)-agonist for treatment of children in a low-income community with high prevalence of asthma. 相似文献
2.
3.
Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
下载免费PDF全文
![点击此处可从《Neuropsychiatric Disease and Treatment》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Christopher L Edwards Renee Dunn Raynor Miriam Feliu Camela McDougald Stephanie Johnson Donald Schmechel Mary Wood Gary G Bennett Patrick Saurona Melanie Bonner Chante Wellington Laura M DeCastro Elaine Whitworth Mary Abrams Patrick Logue Lekisha Edwards Salutario Martinez Keith E Whitfield 《Neuropsychiatric Disease and Treatment》2007,3(6):705-709
Traditionally, neuropsychological deficits due to Sickle Cell Disease (SCD) have been understudied in adults. We have begun to suspect, however, that symptomatic and asymptomatic Cerebrovascular Events (CVE) may account for an alarming number of deficits in this population. In the current brief review, we critically evaluated the pediatric and adult literatures on the neurocognitive effects of SCD. We highlighted the studies that have been published on this topic and posit that early detection of CVE via neurocognitive testing, neuropsychiatric evaluations, and neuroimaging may significantly reduce adult cognitive and functional morbidities. 相似文献
4.
5.
6.
Hillmann JS; Mesgarzadeh M; Revesz G; Bonakdarpour A; Clancy M; Betz RR 《Radiology》1987,165(3):769-773
Proximal femoral focal deficiency, an uncommon congenital anomaly, necessitates early radiologic classification for surgical planning and treatment. Objective radiographic criteria, including femoral length index, acetabular depth index, acetabular angle index, and shape of the proximal femur were determined in 49 patients before cartilaginous ossification of the femoral capital epiphysis; final classification was based on follow-up radiographs or findings at arthrography or surgery. These parameters were analyzed to determine the accuracy and contributions of each in classification. Correct classification into one of three groups was possible in 86% of cases with use of three of the parameters: femoral length index, acetabular depth index, and shape of the proximal femur. The acetabular angle was found to contribute insignificantly to classification. Magnetic resonance imaging, used in only one case, depicted the nonossified cartilaginous femoral capital epiphysis, thus obviating the need for invasive diagnostic procedures and facilitating early classification. 相似文献
7.
Rupture of the distal biceps tendon: evaluation with MR imaging 总被引:2,自引:0,他引:2
8.
9.
LEE JS IM HH JUNG Y JUNG IS JANG JY CHUN YK CHO YD KIM JO CHO JY KIM YS SHIM CS & KIM BS 《Neurogastroenterology and motility》2006,18(6):493-494
Background: Recent development of extracorporeal magnetic stimulation (ECMS) which uses current‐changing magnetic fields allows the induction of electrical stimulation in the desired deep tissue. Recent study showed the sacral nerve stimulation reduces corticoanal excitability that may play a functional role in anal continence mechanisms. Preliminary study shows that ECMS of sacral nerve can modify pelvic floor function and expel rectal balloon in patients with pelvic floor dyssynergia (PFD). Aims: To evaluate the effect of ECMS compared with biofeedback therapy (BF) in patients with PFD. Methods and Materials: Thirty‐eight patients who fulfilled Rome II criteria for PFD by colon transit time and anorectal function tests, were randomly treated with 8 sessions of ECMS (2/weeks; n = 19) at prone position or BF (2/weeks; n = 19) at sitting position. Stimulation parameters were set at 50–80% of maximum intensity, 10 and 50 Hz frequency, 3 s burst length with 3 and 6 s off using arm‐typed stimulator (BioCom‐1000, Mcube Co., Korea). Symptom scores for constipation with/without anorectal function test were repeatedly measured after each treatment. Response was defined as 50% or more decreased symptom score after treatment (partial response: 30–50%, poor: <30%). Results: Fifteen patients (age 49.1 ± 13.4 years, mean ± SD; 4 men) completed 8 session of BF and 14 patients (54.5 ± 17.6 years, 3 men) completed 8 session of ECMS. Four patients of BF group discontinued treatment due to unsatisfactory therapeutic effect (n = 1) and withdrew consent (n = 3) and 5 patients of ECMS group discontinued treatment because of same reasons (n = 1, 4). Total symptom scores were significantly decreased after treatment of 8 session in both treatment groups (13.4 ± 6.6 vs. 4.3 ± 4.0 for BF, p = 0.009; 14.9 ± 5.6 vs. 3.4 ± 4.0 for ECMS, p < 0.001). Bowel movements per week were also significantly increased after treatment in both groups (median 2 vs. 7 for BF, p = 0.035; median 2 vs. 7 for ECMS, p = 0.008). Thirteen out of 15 patients showed response in BF group and 12 out of 14 showed good response in ECMS group. No adverse effects in both groups. Conclusions: ECMS is as effective as BF for the treatment of PFD. Long‐term effect of ECMS for the patients with pelvic floor dyssynergia need to be evaluated in the near future. 相似文献
10.